series-c-plus
Stage
2000
Founded
2
Investors
About
Oncopeptides develops cancer therapies based on proprietary technology, focusing on diseases with significant unmet medical need and advancing science from discovery to commercialization.
Explore Oncopeptides's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.